Body Mass Index, Prostate Cancer–Specific Mortality, and Biochemical Recurrence: a Systematic Review and Meta-analysis
Top Cited Papers
- 1 April 2011
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Prevention Research
- Vol. 4 (4), 486-501
- https://doi.org/10.1158/1940-6207.capr-10-0229
Abstract
Increasing evidence suggested obesity, measured by body mass index (BMI), was associated with prostate cancer–specific mortality, and its impact on biochemical recurrence was also inconclusive. We systematically searched MEDLINE, EMBASE, and bibliographies of retrieved studies up to January 5, 2010. We used random-effects meta-analysis to assess the relative risks (RR) of prostate cancer-specific mortality and biochemical recurrence associated with a 5 kg/m2 increase in BMI. Among the six population-based cohort studies in 1,263,483 initially cancer-free men, 6,817 prostate cancer deaths occurred; a 5 kg/m2 increase in BMI was associated with 15% (RR: 1.15, 95% confidence interval (CI): 1.06–1.25, P < 0.01) higher risk of dying of prostate cancer. In the six postdiagnosis survival studies on 18,203 patients with 932 prostate cancer deaths, a 5 kg/m2 increase in BMI was associated with 20% higher prostate cancer–specific mortality (RR: 1.20, 95% CI: 0.99–1.46, P = 0.06). In the sixteen studies which followed 26,479 prostate cancer patients after primary treatment, a 5 kg/m2 increase in BMI was significantly associated with 21% increased risk of biochemical recurrence (RR: 1.21, 95% CI: 1.11–1.31 P < 0.01). Elevated BMI is associated with risk of prostate cancer–specific mortality in prospective cohort studies and biochemical recurrence in prostate cancer patients. Its association with prostate cancer–specific mortality in diagnosed patients needs to be further evaluated. Cancer Prev Res; 4(4); 486–501. ©2011 AACR.Keywords
This publication has 64 references indexed in Scilit:
- Weight Gain Is Associated with an Increased Risk of Prostate Cancer Recurrence after Prostatectomy in the PSA EraCancer Prevention Research, 2011
- Obesity as a predictor of adverse outcome across black and white raceCancer, 2009
- Impact of Body Mass Index on Biochemical Recurrence Rates After Radical Prostatectomy: An Analysis Utilizing Propensity Score MatchingUrology, 2008
- Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysisThe Lancet Oncology, 2008
- Obesity and oncological outcome after radical prostatectomy: impact of prostate‐specific antigen‐based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center DatabasesBJU International, 2008
- Diabetes and Mortality in Men With Locally Advanced Prostate Cancer: RTOG 92-02Journal of Clinical Oncology, 2008
- Obesity and mortality in men with locally advanced prostate cancerCancer, 2007
- Risk factors for prostate cancer incidence and progression in the health professionals follow‐up studyInternational Journal of Cancer, 2007
- Body size and composition and prostate cancer risk: systematic review and meta-regression analysisCancer Causes & Control, 2006
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986